Prices delayed by at least 15 minutes | Print
Quest Diagnostics (DGX)
Common StockOpen
$138.12
Previous close
$138.16
Trade high
$138.96
Volume
569,562
Year high
$145.58
Year low
$119.59
Dividend yield
2.08%
Market capitalisation
$15.38 bn
P/E ratio
18.59
ISIN
US74834L1008
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Dividends
Previous | Latest | |
---|---|---|
Record date | 17/01/2024 | 08/04/2024 |
Ex-dividend date | 16/01/2024 | 05/04/2024 |
Payment date | 31/01/2024 | 22/04/2024 |
Amount | $0.71 | $0.75 |
Company profile
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.